Articles
Viewpoint: pharma industry myths

Viewpoint: pharma industry myths

Anthony Walker shares his views on the future growth of the industry. Is radical innovation the only route to salvation? Amidst the voluminous commentaries, blogs, tweets, panels and papers about the future of the pharma industry, in some circles certain thoughts seem to be...

Articles
Pharma gets social: five keys to effective corporate blogging – Lessons from JNJBTW

Pharma gets social: five keys to effective corporate bloggin...

Daniel Ghinn continues his series reviewing social media activity in pharma with a look at J&J’s corporate blog - JNJBTW. JNJBTW, Johnson & Johnson’s corporate blog, was one of the company’s early exploits into social media when it launched in 2007 and is …

Articles
Patient perspectives: Meredith Gould

Patient perspectives: Meredith Gould

In our latest patient perspectives interview we speak with Dr Meredith Gould to understand the sociological aspects of medical communication and how the epatient can help pharma. Dr Meredith Gould represents a rare type of epatient who has experience both of managing her disease and in working with pharma to produce...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more